Geroprotectors: The Next Generation of Longevity Ingredients

balkinnutrition
Mar 18
5 min read

Phytonutrients Made Simple | Part 4 of 4

The previous three parts of this series explored plant compounds that support antioxidant defences, cellular protection, and the body's internal detoxification pathways. Part 4 moves into newer territory: geroprotectors.

Geroprotectors are compounds that target the biological mechanisms of ageing itself, not just managing its symptoms, but intervening at the cellular and molecular level to slow or reverse aspects of cellular decline. This emerging category includes Urolithin A, Spermidine, Pterostilbene, and Fisetin, bioactives that are moving from the research laboratory into the premium supplement market with serious scientific momentum^[1,2].

What Are Geroprotectors?

The term geroprotector broadly refers to any compound shown to slow ageing processes in biological systems. What makes the current wave of research distinctive is its focus on specific, measurable cellular mechanisms, particularly mitophagy, autophagy, and senolysis, rather than general antioxidant activity^[3].

The four compounds gaining the most clinical and commercial traction are:

Urolithin A: a postbiotic metabolite produced when gut bacteria process ellagitannins found in pomegranates, walnuts, and berries. It is one of the most clinically advanced geroprotectors, with human trial data supporting its role in mitophagy and muscle health^[4].

Spermidine: a polyamine compound found in wheat germ, fermented foods, aged cheese, and mushrooms. Spermidine is a well-established inducer of autophagy, the cellular 'self-cleaning' process that removes damaged components and maintains cellular health^[5].
Pterostilbene: a methylated analogue of resveratrol found in blueberries and grapes, with significantly better bioavailability. It activates SIRT1 and AMPK pathways associated with metabolic regulation, cellular stress resilience, and aspects of cognitive ageing^[6].

Fisetin: a flavonol found in strawberries, apples, and onions. Fisetin has attracted attention for its senolytic activity: the ability to selectively clear senescent cells, ageing, dysfunctional cells that accumulate in tissues and drive inflammation^[7,8].

How Geroprotectors Work

These compounds act through distinct but complementary mechanisms that together address several hallmarks of biological ageing.

Urolithin A works by inducing mitophagy: the selective clearance of damaged or dysfunctional mitochondria. As mitochondria accumulate damage over time, cellular energy production declines and inflammatory signalling increases. By promoting mitochondrial quality control, Urolithin A supports sustained cellular energy and reduced inflammaging^[4].

Spermidine triggers autophagy more broadly: a process by which cells identify, break down, and recycle damaged proteins and organelles. Autophagy declines with age, and its restoration is increasingly seen as central to healthy longevity. Spermidine activates autophagy by inhibiting EP300, a transcription co-activator that suppresses the process^[5].

Pterostilbene activates SIRT1 (a longevity-associated deacetylase) and AMPK (an energy-sensing kinase), pathways involved in metabolic regulation, DNA repair, and cellular stress adaptation. Its structural advantage over resveratrol, two methoxy groups versus two hydroxy groups, gives it significantly higher oral bioavailability and a longer half-life in tissues^[6].

Fisetin operates partly as a senolytic: clearing senescent cells that have stopped dividing but remain metabolically active, secreting pro-inflammatory signals collectively known as the senescence-associated secretory phenotype (SASP). Reducing SASP burden is a key target in longevity medicine, and fisetin is one of the few dietary compounds with meaningful preclinical senolytic data^[7,8].

What the Research Tells Us

The human evidence base for geroprotectors is growing, though it remains earlier-stage than for polyphenols or carotenoids. Urolithin A has the most advanced clinical data: randomised trials in older adults show significant improvements in skeletal muscle mitochondrial gene expression and improved exercise performance, alongside favourable safety profiles^[4,9].

Spermidine's longevity associations come partly from epidemiological data, populations with higher dietary spermidine intake show associations with reduced all-cause mortality, and from clinical pilot studies suggesting improvements in memory performance in older adults^[5,10].

Pterostilbene has human pharmacokinetic data confirming its superior absorption compared to resveratrol, and early clinical work suggesting positive effects on blood pressure, lipid profiles, and oxidative stress markers^[6]. Fisetin's human data are more limited, but preclinical work is compelling: mouse studies show extended lifespan and improved healthspan metrics with fisetin supplementation^[7,8].

The consistent theme across this category is that these compounds target the upstream drivers of ageing, mitochondrial decline, protein accumulation, and cellular senescence, rather than downstream consequences. This mechanistic sophistication is what distinguishes geroprotectors from conventional antioxidants.

The Product Side

Geroprotectors represent a significant commercial opportunity in the premium supplements market, where consumers are increasingly willing to pay for evidence based, mechanism led products. Key considerations for brands entering this space:

Urolithin A is already commercially available as a standardised ingredient (notably as Mitopure®), with clinical backing that supports marketing in the sports nutrition and healthy ageing categories. Its postbiotic origin story, produced by gut bacteria from pomegranate derived compounds, also resonates with microbiome aware consumers.

Spermidine is commercially sourced from wheat germ extract and is increasingly positioned in cognitive health and longevity formulations. The autophagy narrative is still emerging in mainstream consumer awareness, giving early-moving brands a positioning advantage.

Pterostilbene's superior bioavailability over resveratrol is a compelling differentiator, and its activation of SIRT1 pathways allows it to be positioned credibly within the 'metabolic optimisation' and 'longevity science' narratives.

Fisetin is gaining traction in the senolytic supplements category, though the human evidence is still developing. Brands entering this space should communicate the science carefully, positioning around the emerging research rather than making direct health claims.

Regulatory awareness is essential. In the UK and EU, no health claims are authorised for these compounds under EFSA's framework. Brands must communicate their science credibly without crossing into unauthorised efficacy claims, focusing on mechanisms, ingredient provenance, and emerging research rather than therapeutic outcomes.

The Takeaway

Geroprotectors mark a genuine shift in how we think about nutrition and ageing. Rather than managing the consequences of cellular decline, they target the mechanisms that drive it: mitophagy, autophagy, senolysis, and metabolic regulation. The science is maturing rapidly, and the commercial infrastructure is following.

For founders and brand builders, this category represents the frontier of functional nutrition: ingredients with credible biological rationale, a growing body of human evidence, and a consumer audience that is increasingly sophisticated and willing to engage with the science. The brands that invest in understanding and communicating these mechanisms now will be well positioned as this category moves towards mainstream adoption.

Subscribe to Our Latest Insights & Articles

References

Lopez-Otin C, et al. (2013). The Hallmarks of Aging. Cell, 153(6):1194–1217. https://www.cell.com/cell/fulltext/S0092-8674(13)00645-4
Partridge L, Deelen J, Slagboom PE (2018). Facing Up to the Global Challenges of Ageing. Nature, 561:45–56. https://www.nature.com/articles/s41586-018-0457-8
Rattan SIS (2012). Biogerontology: Research Status, Challenges and Opportunities. Acta Biochimica Polonica, 59(2):249–253.
Andreux PA, et al. (2019). The Mitophagy Activator Urolithin A Is Safe and Induces a Molecular Signature of Improved Mitochondrial and Cellular Health in Humans. Nature Metabolism, 1:595–603. https://www.nature.com/articles/s42255-019-0073-4
Eisenberg T, et al. (2016). Cardioprotection and Lifespan Extension by the Natural Polyamine Spermidine. Nature Medicine, 22(12):1428–1438. https://www.nature.com/articles/nm.4222
McCormack D, McFadden D (2013). A Review of Pterostilbene Antioxidant Activity and Disease Modification. Oxidative Medicine and Cellular Longevity, 2013:575482. https://www.hindawi.com/journals/omcl/2013/575482/
Yousefzadeh MJ, et al. (2018). Fisetin is a Senotherapeutic That Extends Health and Lifespan. EBioMedicine, 36:18–28. https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(18)30373-6/fulltext
Kirkland JL, Tchkonia T (2020). Senolytic Drugs: From Discovery to Translation. Journal of Internal Medicine, 288(5):518–536. https://onlinelibrary.wiley.com/doi/full/10.1111/joim.13141
Liu S, et al. (2022). Urolithin A Improves Muscle Strength, Exercise Performance, and Biomarkers of Mitochondrial Health in Older Adults. JAMA Network Open, 5(1):e2144279. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2788222
Kiechl S, et al. (2018). Higher Spermidine Intake is Linked to Lower Mortality: A Prospective Population-Based Study. American Journal of Clinical Nutrition, 108(2):371–380. https://academic.oup.com/ajcn/article/108/2/371/5051122